Constellium SE: BMO cuts target price to $36 from $40
CSTM•BMO cut its target price for Constellium to $36 from $40.
Related News
Keros doses first patient in Phase 2 rinvatercept trial for Duchenne muscular dystrophy
KROS•
Fitch says China accelerates small-bank cleanup to preserve financial stability
FXI•
Volato Alignment Engine signs $1.17 billion AI infrastructure orders with large AI customer
SOAR•
Scholastic Corporation: B. Riley Securities cuts target price to $35 from $42
SCHL•
Western Asset Global Corporate Opportunity Fund NAV per share falls to $11.14 for quarter ended July 31, 2026
GDO•